Literature DB >> 20605819

Hepatitis B virus-related polyarteritis nodosa presenting with multiple lung nodules and cavitary lesions.

Taio Naniwa1, Tomoyo Maeda, Shigeki Shimizu, Rei Ito.   

Abstract

The patient presented here is a 59-year-old Japanese man with active chronic hepatitis B with precore and core promoter mutated virus, presenting with high fever, bloody sputum, and multiple lung nodules with excavation. Surgical biopsy of the lung nodule showed necrotizing vasculitis affecting pulmonary arteries without granulomatous changes. The pulmonary manifestations of this patient resembled Wegener granulomatosis. However, the pathologic findings showing nongranulomatous necrotizing vasculitis involving the small pulmonary arteries, presence of circulating immune complex, absence of antineutrophil cytoplasmic antibodies, and excellent response to the combination therapy of corticosteroid and an anti-hepatitis B virus agent, entecavir, led us to the diagnosis of hepatitis B virus-related polyarteritis nodosa (PAN). Radiographic evidence of lung nodules or cavitations seen in systemic vasculitis patients has been considered a sign suggestive of granulomatous disease and a diagnostic surrogate marker for necrotizing granulomatous vasculitis, but a clinical relevance to hepatitis B virus-related PAN has not been reported before this case.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605819     DOI: 10.1378/chest.09-2579

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

Review 1.  Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis.

Authors:  Aman Sharma; Kusum Sharma
Journal:  J Clin Exp Hepatol       Date:  2013-07-08

2.  Hepatitis B Virus-associated Vasculitis: Multiple Cavitary Masses in the Lung Mimicking Granulomatous Polyangiitis.

Authors:  Masahiro Nemoto; Kenjin Nishioka; Jun Fukuoka; Masahiro Aoshima
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.